JRNYS Review

What JRNYS charges

• NAD+: $219/mo — from, per month; read off the /longevity index because the product's own page prints only its neighbour's price
• Glutathione: $149/mo — from, per month; read off the /longevity index because the product's own page prints only its neighbour's price
• Tirzepatide: $216/mo — from, per month; the product page carries no figure, so this is read from the /products listing

JRNYS also sells 3 compounds this site boards without publishing a price for them: BPC-157 (board ranks no provider), TB-500 (board ranks no provider) and PT-141.

Each product page shows its neighbour's price

The NAD+ page carries no figure of its own; what it shows is a related-products carousel displaying the glutathione price.

The glutathione page does the same in reverse, showing the NAD+ product and its figure.

A reader taking the number from the page it appears on would come away with both prices swapped. The attribution recorded here was confirmed against the longevity index, which lists both pairs correctly, twice each.

Its own FAQ contradicts its own price pages

The FAQ says medication pricing is confirmed after the provider consultation.

Its longevity index and its products listing publish fixed starting-from figures for those same medications.

Both are the seller's own statements, they disagree, and neither corrects the other. That is left unresolved here rather than smoothed.

The membership floor is not a drug price

The site advertises a membership starting figure and repeats it as the membership's own starting rate.

That floor covers all of its weight-loss medicines at once rather than any one of them.

Nothing is filed from it, because a figure covering several drugs is not a price for any single one.

What it says about who dispenses

Its terms say prescriptions may be transferred among the pharmacies without notice, which is unusually direct.

No dispensing pharmacy is named anywhere on the pages read, and no certificate of analysis is published.

The pages read make no state-coverage claim, so no state list is recorded.

How we verified this

• Read each longevity product page, found it carries only its neighbour's figure in a related-products carousel, and refused to file either number from the page it appeared on.
• Confirmed the correct attribution against the longevity index, which lists both product-and-figure pairs correctly, twice each.
• Read the membership starting figure in its own context, confirmed it covers several weight-loss medicines at once, and filed nothing from it.
• Requested a deliberately meaningless address on this host in the same session and confirmed it returns a not-found response.
• Screened the brand against the live federal warning-letter table, pulling all 3,677 records in pages and filtering locally because the table's own search parameter is ignored, with a positive and a nonsense control in the same run. No letters.